Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Clinical trial NCT06060613 · RECRUITING

Trial details

NCT number: NCT06060613
Sponsor: Obsidian Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Tumor Skin Metastatic Melanoma Melanoma Lung Cancer Metastatic Lung Cancer Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer

Start date: 2023-10-25
Primary completion: 2029-06-30
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.